Antina Schulze

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle et al. · Journal of Cancer Research and Clinical Oncology · 2006 · 190 citations · Full text

Hematological Malignancy, Medicine, Metronomic Therapy +10

Effects of surgical face masks on cardiopulmonary parameters during steady state exercise

Johannes Lässing, Roberto Falz, Christoph Pökel et al. · Scientific Reports · 2020 · 122 citations · Full text

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

Michael Herold, Antina Schulze, Dietger Niederwieser et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 103 citations · Full text

Lymphoid Neoplasia, Oncology, Mantle Cell Lymphoma +8

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

Nadežda Basara, Antina Schulze, Ulrich Wedding et al. · Leukemia · 2009 · 79 citations

Hematological Malignancy, Radiation Oncology, Conventional Chemotherapy +15

Comparison of the effect of GIP and GLP‐1 (7–36amide) on insulin release from rat pancreatic islets

E. G. Siegel, Antina Schulze, Wolfgang E. Schmidt et al. · European Journal of Clinical Investigation · 1992 · 40 citations